US Patent Issued to HDT Bio on March 25 for "SARS-CoV-2 RNA vaccine compositions and methods of use" (Washington Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,299, issued on March 25, was assigned to HDT Bio Corp. (Seattle).

"SARS-CoV-2 RNA vaccine compositions and methods of use" was invented by Steven Gregory Reed (Bellevue, Wash.), Darrick Albert Carter (Seattle), Amit Praful Khandhar (Issaquah, Wash.), Jacob Freeman Archer (Seattle), Lars Peter Aksel Berglund (Seattle), Jesse Erasmus (Port Orchard, Wash.), Bryan Berube (Issaquah, Wash.) and Malcolm S. Duthie (Sammamish, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides compositions, methods of treatment, and methods of making and using compositions to deliver a nucleic acid to a subject. Methods of using the compositions as...